Epigallocatechin Gallate for COVID-19
2 studies with >1,000 patients
Hospital Icon Control Serious Outcome Risk
Hospital Icon Epigallocatechin Gallate
One study shows significant benefit.
COVID-19 Epigallocatechin Gallate studies. Jun 2026. c19early.org
0 0.5 1 1.5+ All studies 38% Hospitalization 67% Cases 1% RCTs 38% Prophylaxis 67% Late 38% Favorsepigallocatechin gallate Favorscontrol
EGCG (epigallocatechin gallate) is a small molecule polyphenol derived from Camellia sinensis that exhibits antiviral activity against SARS-CoV-2 via dual mechanisms: blocking viral entry by interfering with the Spike-ACE2 receptor interaction and inhibiting the viral 3CL protease (Mpro). Additionally, EGCG provides anti-inflammatory effects by modulating cytokine production, potentially mitigating the cytokine storm associated with severe COVID-19. Recent:
Kawai
Zhu.
Jun 21
Covid Analysis Meta-analysis of epigallocatechin gallate studies
Meta-analysis of epigallocatechin gallate studies
May 31
Kawai et al., AJPM Focus, doi:10.1016/j.focus.2026.100517 Effects of green tea gargling on Coronavirus Disease-2019: A multi-center randomized controlled trial
67% lower hospitalization (p=0.5), 67% lower progression (p=0.5), and 1% fewer cases (p=1). RCT 1,012 adults in Japan showing no statistically significant reduction in COVID-19 incidence with green tea gargling compared to water gargling. In the full analysis set, incidence was 5.4% in both groups. In the per-protocol set (PPS, ..
Jan 19
Zhu et al., BMC Cancer, doi:10.1186/s12885-026-15553-x Efficacy and safety of 7-day aerosolized epigallocatechin-3-gallate in oncologic patients with COVID-19 pneumonia
38% greater improvement (p=0.002). RCT 108 hospitalized oncologic patients with COVID-19 pneumonia showing significant benefit with aerosolized epigallocatechin-3-gallate (EGCG). The EGCG group showed significantly greater CT imaging improvement (64.8% vs 40.5%, P=0.004) a..
Jan 9
2025
Williams, R., Cureus, doi:10.7759/cureus.77188 COVID-19 Humic/Fulvic Acid Plus Epigallocatechin Gallate Treatment: A Retrospective Chart Review
97% lower mortality (p<0.0001). Retrospective 60 COVID-19 patients in a nursing home facility showing no mortality with EGCG (from green tea extract), humic/fulvic acid, and vitamin C treatment, compared to 55% mortality in the control group not receiving treatment. The..
Apr 17
2024
Yin et al., BMC Cancer, doi:10.1186/s12885-024-12228-3 Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer
Phase I/II trial of EGCG nebulization inhalation in 54 COVID-19 pneumonia patients with cancer showing good tolerability and improvement in CT scans in 56% of patients after 7 days, with non-progression of pneumonia in 82% of patients. Th..
Dec 31
2023
Daskou et al., Pathogens, doi:10.3390/pathogens13010039 The Role of the NRF2 Pathway in the Pathogenesis of Viral Respiratory Infections
Review discussing the role of the NRF2 antioxidant pathway in regulating viral replication and associated inflammation and cell damage pathways during respiratory viral infections. Authors summarize evidence showing that respiratory virus..
Apr 13
2023
Barh et al., Indian Journal of Medical Research, doi:10.4103/ijmr.ijmr_1701_22 Indian food habit & food ingredients may have a role in lowering the severity & high death rate from COVID-19 in Indians: findings from the first nutrigenomic analysis
Nutrigenomics study of blood transcriptomes from Indian and western COVID-19 patients, showing Indian dietary habits and food ingredients including higher zinc, iron, curcumin, fiber, catechins, and EGCG may be associated with reduced sev..
Jun 7
2022
Storozhuk, M., medRxiv, doi:10.1101/2022.06.06.22276060 COVID-19 and per capita green tea consumption: update
Ecological study comparing 134 countries/territories showing lower COVID-19 morbidity and mortality associated with higher per capita green tea consumption. The differences remained significant when excluding countries with low human deve..